153 related articles for article (PubMed ID: 11696170)
1. Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas.
Miyake N; Maeta H; Horie S; Kitamura Y; Nanba E; Kobayashi K; Terada T
Pathol Int; 2001 Sep; 51(9):680-5. PubMed ID: 11696170
[TBL] [Abstract][Full Text] [Related]
2. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
5. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.
Aust DE; Terdiman JP; Willenbucher RF; Chang CG; Molinaro-Clark A; Baretton GB; Loehrs U; Waldman FM
Cancer; 2002 Mar; 94(5):1421-7. PubMed ID: 11920497
[TBL] [Abstract][Full Text] [Related]
6. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.
Kotsinas A; Evangelou K; Zacharatos P; Kittas C; Gorgoulis VG
Am J Pathol; 2002 Nov; 161(5):1619-34. PubMed ID: 12414510
[TBL] [Abstract][Full Text] [Related]
7. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
8. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Kurihara K; Shimizu S; Chong J; Hishima T; Funata N; Kashiwagi H; Nagai H; Miyaki M; Fukayama M
Jpn J Cancer Res; 2000 Nov; 91(11):1100-2. PubMed ID: 11092973
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract][Full Text] [Related]
12. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
13. beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.
Rezk S; Brynes RK; Nelson V; Thein M; Patwardhan N; Fischer A; Khan A
Endocr Pathol; 2004; 15(4):329-37. PubMed ID: 15681857
[TBL] [Abstract][Full Text] [Related]
14. [Roles of beta-catenin overexpression and adenomatous polyposis coli mutation in head and neck cancer].
Takei S; Ueno Y; Yoda J; Tamura S; Hotomi M; Fujihara K; Kuki K; Yamanaka N
Nihon Jibiinkoka Gakkai Kaiho; 2003 Jun; 106(6):692-9. PubMed ID: 12872724
[TBL] [Abstract][Full Text] [Related]
15. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
16. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
Garcia-Rostan G; Camp RL; Herrero A; Carcangiu ML; Rimm DL; Tallini G
Am J Pathol; 2001 Mar; 158(3):987-96. PubMed ID: 11238046
[TBL] [Abstract][Full Text] [Related]
18. Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Tsutsumi M; Sasaki Y; Murata N; Konishi Y
Cancer Res; 2000 Dec; 60(23):6611-6. PubMed ID: 11118043
[TBL] [Abstract][Full Text] [Related]
19. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
